Table 2.
Operative outcomes in the two study groups (HCC and metastases).
| Outcome | HCC (14 Lesions in 11 Patients) |
Metastases (50 Lesions in 38 Patients) | p Value |
|---|---|---|---|
| Technical success | 14 (100%) | 50 (100%) | - |
| Complete ablation at 1 month | 11 (79%) | 48 (96%) | 0.032 * |
| Patients with local recurrence | 5 (45%) | 11(29%) | 0.477 |
| Total number of Local Recurrence |
6 (43%) | 14 (28%) | 0.289 |
| Patients with local tumor progression | 1 (7%) | 5 (10%) | 0.105 |
| Patients with distant metastases | 1 (7%) | 6 (12%) | 0.607 |
| Patients with minor complications | 1 (9%) | 5 (13%) | 0.730 |
| Redo liver CrA | 2 (14%) | 8 (16%) | 0.864 |
* statistically significant.